Corvus Pharmaceuticals, Inc. (CRVS) Earnings Per Share (EPS)
Corvus Pharmaceuticals, Inc. (CRVS) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | -$1.59 |
| 2020-12-31 | -$0.20 |
| 2021-12-31 | -$1.03 |
| 2022-12-31 | -$0.89 |
| 2023-12-31 | -$0.56 |
| 2024-12-31 | -$1.02 |
| 2025-12-31 | -$0.19 |
How CRVS compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ACRS | Aclaris Therapeutics Inc. | -$0.53 |
| STIM | Neuronetics Inc. | -$0.59 |
| DMAC | DiaMedica Therapeutics Inc. | -$0.70 |
| GOSS | Gossamer Bio Inc. | -$0.75 |
| EOLS | Evolus Inc. | -$0.80 |
These are five companies in the same sector as CRVS with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Corvus Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("CRVS")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CRVS | $13.74 | -1.29% | 0.94M |
| 3 | ||||
| 4 | ||||
| 5 |